CureApp Launches “Everyone’s Salt Reduction Festival” Ahead of World Hypertension Day, Highlighting Barriers Patients Face in Sustaining Low-Salt Diets

CureApp, Inc. announced that it conducted a survey on food-related attitudes among 800 hypertension patients in their 40s to 70s across Japan ahead of World Hypertension Day on May 17. The survey found that while many patients understand the importance of reducing salt intake, they struggle to continue doing so because of dissatisfaction with taste and the effort required to cook or search for recipes. According to the survey, 47% of respondents said that thoroughly reducing salt intake is important for improving hypertension, but only 25% said they are actually able to maintain a low-salt diet, revealing a major gap between awareness and behavior. In addition, 46% said reducing salt itself is difficult. Key barriers included food tasting unsatisfying at 29% and meals lacking satisfaction at 16%. Another 12% said they often use prepared foods and cannot adjust salt content, while 10% said they do not know low-salt recipes or cooking methods. The survey also showed that nutrition balance and calorie management in modern diets are affected by time performance and cost performance. Twenty-one percent said it is difficult to eat enough vegetables and fruit every day, 13% cited high prices, and 10% said cooking takes too much time and effort. For calorie control, 16% said calculations are troublesome and 12% said they do not know the calories in foods. To address these barriers to salt reduction, CureApp launched the lifestyle improvement awareness campaign “Everyone’s Salt Reduction Festival” on May 14, 2026. The campaign is held in collaboration with Kagome, Yamaki, Otsuka Foods, and Oisix ra daichi, offering solutions that help people begin an enjoyable low-salt lifestyle. Participants can enter a prize draw by answering a lifestyle questionnaire on the campaign website. The campaign runs from May 14 to June 17, 2026. Prizes include a vegetable harvesting and tasting experience from Kagome, a low-salt dashi set from Yamaki, a properly salted retort food set from Otsuka Foods, doctor-supervised meal kits from Oisix, and a salt-reduction temple lodging experience from CureApp. Founded in 2014 by two physicians, CureApp is a medical device manufacturer that researches, develops, manufactures, and sells prescription therapeutic apps whose clinical effects have been proven in trials. The company has obtained regulatory approval and insurance coverage for therapeutic apps in smoking cessation, hypertension, and alcohol reduction treatment, and is also developing apps for conditions such as NASH, cancer, chronic heart failure, and chronic low back pain.